Skip to main content

Articles

Page 3 of 324

  1. This study aims to explore the priorities and counselling needs of patients with muscle-invasive bladder cancer faced with a decision between radical cystectomy and trimodality therapy.

    Authors: Flor Verghote, Charles Van Praet, Camille Berquin, Nicolaas Lumen, Karel Decaestecker, Ben Vanneste, Elke Rammant and Valérie Fonteyne
    Citation: BMC Cancer 2024 24:160
  2. This study was designed to evaluate the safety and feasibility of laparoscopic radical cystectomy (LRC) for male octogenarian patients with muscle-invasive bladder cancer (MIBC). Briefly, a total of 57 male oc...

    Authors: Dong-liang Pan, Lu-fang Zhang, Xiao-jian Li, Ke-ping Zhang, Peng-fei Gao, Bing Yang and Ning-chen Li
    Citation: BMC Cancer 2024 24:159
  3. Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspective...

    Authors: Kathryn E. Weaver, Emily V. Dressler, Sydney Smith, Chandylen L. Nightingale, Heidi D. Klepin, Simon Craddock Lee, Brian J. Wells, W. Gregory Hundley, Joseph A. DeMari, Sarah N. Price and Randi E. Foraker
    Citation: BMC Cancer 2024 24:158
  4. The increasing cancer burden calls for reliably assessed changes in the hospitalizations for tumors over time and space in China. This study evaluated trends in hospitalization rate, in-hospital mortality, len...

    Authors: Xinqiang Zhang, Yuanyuan Li, Guifang Zhang, Changsheng Ma, Bo Liu and Yong Yin
    Citation: BMC Cancer 2024 24:154
  5. Neoadjuvant immune checkpoint inhibitors(ICIs) combined with chemotherapy can improve non-small cell lung cancer(NSCLC) patients' pathological responses and show promising improvements in survival. Chronic obs...

    Authors: Weigang Dong, Yan Yin, Shengnan Yang, Bin Liu, Xi Chen, Lina Wang, Yue Su, Yan Jiang, Dongsheng Shi, Daqiang Sun and Jianwen Qin
    Citation: BMC Cancer 2024 24:153
  6. While immunotherapy combined with chemotherapy (Chemo-IO) is generally recognized for providing superior outcomes compared to monotherapy (mono-IO), it is associated with a higher incidence of treatment-relate...

    Authors: Sangwon Shin, Jimin Moon, Chiyoon Oum, Seulki Kim, Soo Ick Cho, Yoojoo Lim, Chan-Young Ock and Seunghwan Shin
    Citation: BMC Cancer 2024 24:152
  7. Breast cancer in Tunisia is often diagnosed at a late stage with long delay in time to consultation and to diagnosis.The aim of this study is to estimate the sensitivity and specificity of the transcutaneous b...

    Authors: Imtinene Belaid, Mohamed Fedy Baya, Saif Ben Ayed, Ali Ben Ayed, Jihen Maatoug, Nawel Zommit, Mohamed Anas Trabelsi, Noureddine Ben Chida, Hedi Khairi, Leila Ben Fatma, Imene Chabchoub, Nouha Ammar, Rym Bourigua, Makrem Hochlaf, Faten Ezzaari and Slim Ben Ahmed
    Citation: BMC Cancer 2024 24:151
  8. The existing staging system cannot meet the needs of accurate survival prediction. Accurate survival prediction for locally advanced cervical cancer (LACC) patients who have undergone concurrent radiochemother...

    Authors: Huiling Liu, Yongbin Cui, Cheng Chang, Zichun Zhou, Yalin Zhang, Changsheng Ma, Yong Yin and Ruozheng Wang
    Citation: BMC Cancer 2024 24:150
  9. Physician-brief advice has been utilized in high-income countries to promote smoking cessation among cancer patients. Empirical evidence on its effectiveness among cancer patients in low and middle-income coun...

    Authors: Olayinka Stephen Ilesanmi, Babalola Faseru, Aanuoluwapo Adeyimika Afolabi, Olukemi Odukoya, Olalekan Ayo-Yusuf, Folahanmi Akinsolu, Akindele Olupelumi Adebiyi and William K. Evans
    Citation: BMC Cancer 2024 24:149
  10. We aimed to identify preoperative predictors of aggressive pathology for cT1 solid renal cell carcinoma (RCC) by combining clinical features with qualitative and quantitative CT parameters, and developed a nom...

    Authors: Keruo Wang, Liang Dong, Songyang Li, Yaru Liu, Yuanjie Niu and Gang Li
    Citation: BMC Cancer 2024 24:148
  11. Pediatric low-grade glioma (pLGG) is essentially a single pathway disease, with most tumors driven by genomic alterations affecting the mitogen-activated protein kinase/ERK (MAPK) pathway, predominantly KIAA1549:...

    Authors: Cornelis M. van Tilburg, Lindsay B. Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A. Azizi, Ofelia Cruz-Martínez, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten-van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch…
    Citation: BMC Cancer 2024 24:147
  12. Life expectancy of patients with metastatic castration-resistant prostate cancer (mCRPC) is still limited despite several systemic treatments. Within five years after diagnosis of primary prostate cancer, 10–2...

    Authors: Sui wai Ling, Astrid A. M. van der Veldt, Mark Konijnenberg, Marcel Segbers, Eline Hooijman, Frank Bruchertseifer, Alfred Morgenstern, Erik de Blois and Tessa Brabander
    Citation: BMC Cancer 2024 24:146
  13. Up to 70% of people diagnosed with upper gastrointestinal (GI) tract or hepato-pancreato-biliary (HPB) cancers experience substantial reductions in quality of life (QoL), including high distress levels, pain, ...

    Authors: Patricia M Livingston, Natalie Winter, Anna Ugalde, Liliana Orellana, Antonina Mikocka-Walus, Michael Jefford, John Zalcberg, Neil Orford, Alison M Hutchinson, Andrew Barbour, Nicole Kiss, Bernard Mark Smithers, David I Watson, Nikki McCaffrey and Victoria White
    Citation: BMC Cancer 2024 24:144
  14. The COVID-19 pandemic might have delayed cancer diagnosis and management. The aim of this systematic review was to compare the initial tumor stage of new cancer diagnoses before and after the pandemic.

    Authors: Simon Marty, Guillaume Lamé, Etienne Guével, Sonia Priou, Gilles Chatellier, Christophe Tournigand and Emmanuelle Kempf
    Citation: BMC Cancer 2024 24:143
  15. The prognostic significance of mast cells and different phenotypes of macrophages in the microenvironment of hepatocellular carcinoma (HCC) following resection is unclear. We aimed in this study to assess the ...

    Authors: Esraa Ali, Lenka Červenková, Richard Pálek, Filip Ambrozkiewicz, Petr Hošek, Ondrej Daum, Václav Liška, Kari Hemminki and Andriy Trailin
    Citation: BMC Cancer 2024 24:142
  16. Gastric cancer (GC) remains a predominant form of malignant tumor globally, necessitating innovative non-surgical therapeutic approaches. This investigation aimed to delineate the expression landscape of macro...

    Authors: Zhijun Hong, Peizhen Wen, Kang Wang, Xujin Wei, Wen Xie, Shihao Rao, Xin Chen, Jingjing Hou and Huiqin Zhuo
    Citation: BMC Cancer 2024 24:141
  17. Glioblastoma multiforme (GBM) is the most aggressive brain cancer with a poor prognosis. Therefore, the correlative molecular markers and molecular mechanisms should be explored to assess the occurrence and tr...

    Authors: Wangyang Yu, Minfeng Zhou, Huifang Niu, Jinxiao Li, Qiumeng Li, Xiaoyun Xu, Fengxia Liang and Chen Rui
    Citation: BMC Cancer 2024 24:140
  18. Identifying lymph node metastasis areas during surgery for early invasive lung adenocarcinoma remains challenging. The aim of this study was to develop a nomogram mathematical model before the end of surgery f...

    Authors: Mengchao Xue, Junjie Liu, Zhenyi Li, Ming Lu, Huiying Zhang, Wen Liu and Hui Tian
    Citation: BMC Cancer 2024 24:139
  19. Central nervous system (CNS) tumors are the most common solid tumors in children and the leading cause of cancer-related death in the latter. Currently, the incidence rate exceeds that of leukemia and ranks fi...

    Authors: Bing Yao, Hongying Wang, Xiaomei Wu, Chenyu Wang, Tao Tang, Wenxiu An and Bo Zhu
    Citation: BMC Cancer 2024 24:138
  20. Forkhead-box protein P1 (FOXP1) has been proposed to have both oncogenic and tumor-suppressive properties, depending on tumor heterogeneity. However, the role of FOXP1 in intrahepatic cholangiocarcinoma (ICC) ...

    Authors: Chenwei Tang, Hongkai Zhuang, Huanjun Tong, Xiaopeng Yu, Jialu Chen, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Yonglin Hua, Changzhen Shang and Zhaohui Tang
    Citation: BMC Cancer 2024 24:137
  21. Despite the utilization of immune checkpoint inhibitors (ICIs) in treating numerous types of cancers being approved, their efficacy in tumor control in the clinic is not satisfactory. Since adoptive cell thera...

    Authors: Yi-Ping Hung, Chia-Chun Tu, Jiun-I Lai, Muh-Hwa Yang, Jan-Mou Lee and Yee Chao
    Citation: BMC Cancer 2024 24:136
  22. Glioblastoma is the most frequent and a particularly malignant primary brain tumor with no efficacy-proven standard therapy for recurrence. It has recently been discovered that excitatory synapses of the AMPA-...

    Authors: Sophie Heuer, Ina Burghaus, Maria Gose, Tobias Kessler, Felix Sahm, Philipp Vollmuth, Varun Venkataramani, Dirk Hoffmann, Matthias Schlesner, Miriam Ratliff, Carsten Hopf, Ulrich Herrlinger, Franz Ricklefs, Martin Bendszus, Sandro M. Krieg, Antje Wick…
    Citation: BMC Cancer 2024 24:135
  23. Neoadjuvant chemotherapy with dual-targeted therapy is the standard treatment for human epidermal growth factor 2 (HER2)-positive breast cancer. Although the dual-targeted therapy has significantly improved th...

    Authors: Zheng-Jun Yang, Fei Xin, Zu-Jin Chen, Yue Yu, Xin Wang and Xu-Chen Cao
    Citation: BMC Cancer 2024 24:134
  24. There are limited and no standard therapies for recurrent glioblastoma. We herein report the antitumour activity and safety of sintilimab, bevacizumab and temozolomide (TMZ) in recurrent glioblastoma.

    Authors: Yinghao Lu, Limin Liao, Kunpeng Du, Jianhua Mo, Xia Zou, Junxian Liang, Jiahui Chen, Wenwen Tang, Liwei Su, Jieping Wu, Junde Zhang and Yujing Tan
    Citation: BMC Cancer 2024 24:133
  25. Studies have revealed that acute myeloid leukemia (AML) patients are prone to combined cardiac injury. We aimed to identify hematological risk factors associated with cardiac injury in newly diagnosed AML pati...

    Authors: Linlu Ma, Qian Wang, Xinqi Li, Yufeng Shang, Nan Zhang, Jinxian Wu, Yuxing Liang, Guopeng Chen, Yuxin Tan, Xiaoyan Liu, Guolin Yuan and Fuling Zhou
    Citation: BMC Cancer 2024 24:132
  26. Current guidelines advocate for colorectal cancer (CRC) screening in adults who are at risk by using direct visualization methods such as colonoscopy. However, in Egypt, there is a paucity of data regarding th...

    Authors: Abdallah R. Allam, Mostafa A. Elsayed, Ibrahim Tawfiq Daghash, Ali M. Abdelaziz, Omnia M. Mostafa, Hamdy Khaled Sabra, Ahmed Monib Eldaboush, Noor Maged Badrawy Ahmed, Rawan Tarek Elweza, Enas Sherif Adwy, Abdelrahman Elbendary Hammad, Ibrahim Ali Kabbash, Ahmed Hafez Allam, Ammar Ayman Bahbah, Marwa Ibrahim Ewis, Mohamed Mohamed Shawqi…
    Citation: BMC Cancer 2024 24:131
  27. Treatment summaries and a personalized survivorship care plans based on internationally approved, organ-specific follow-up care recommendations are essential in preserving the health and quality of life for ca...

    Authors: Charlotte Demoor-Goldschmidt, Pascal Veillon, Maxime Esvan, Mathilde Leonard, Sophie Chauvet, Amandine Bertrand, Liana Carausu, Fanny Delehaye, Julien Lejeune, Jérémie Rouger, Pascale Schneider, Caroline Thomas, Frédéric Millot, Line Claude, Julie Leseur, Fernand Missohou…
    Citation: BMC Cancer 2024 24:130
  28. Esophageal cancer (EC) is a deadly disease with limited therapeutic options. Although circulating tumor DNA (ctDNA) could be a promising tool in this regard, the availiable evidence is limited. We performed a ...

    Authors: Yaozhong Zhang, Huazhen Du, Na Wang, Lei Wang and Yajie Huang
    Citation: BMC Cancer 2024 24:129
  29. Sarcopenia has been identified as a potential negative prognostic factor in cancer patients. In this study, our objective was to investigate the relationship between the assessment method for sarcopenia using ...

    Authors: Katsuya Sakamoto, Shin-ichiro Hiraoka, Kohei Kawamura, Peiying Ruan, Shuji Uchida, Ryo Akiyama, Chonho Lee, Kazuki Ide and Susumu Tanaka
    Citation: BMC Cancer 2024 24:128
  30. To present the widely unknown perioperative outcomes and continence status of bladder cancer patients following robotic-assisted radical cystectomy (RARC) with Mainz pouch II urinary diversion (UD).

    Authors: Suoshi Jing, Enguang Yang, Zuoxi Luo, Yunxin Zhang, Hui Ding, Li Yang, Zhilong Dong, Panfeng Shang, Zhongjin Yue, Gongjin Wu, Junsheng Bao, Junqiang Tian, Jiaji Wang, Nan Xiao and Zhiping Wang
    Citation: BMC Cancer 2024 24:127
  31. Adolescents and young adults (AYAs) with cancer, defined as individuals aged 15–39 years at initial cancer diagnosis, form a unique population; they face age-specific issues as they transition to adulthood. Th...

    Authors: Olga Husson, Silvie H. M. Janssen, Bryce B. Reeve, Samantha C. Sodergren, Christabel K. Cheung, Martin G. McCabe, John M. Salsman, Winette T. A. van der Graaf and Anne-Sophie Darlington
    Citation: BMC Cancer 2024 24:126
  32. T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a cell surface molecule that was first discovered on T cells. However, recent studies revealed that it is also highly expressed in acute myeloid l...

    Authors: Hooriyeh Shapourian, Mustafa Ghanadian, Nahid Eskandari, Abolfazl Shokouhi, Gülderen Yanikkaya Demirel, Alexandr V. Bazhin and Mazdak Ganjalikhani-Hakemi
    Citation: BMC Cancer 2024 24:125
  33. HLX01 (HanliKang®) is a rituximab biosimilar that showed bioequivalence to reference rituximab in untreated CD20-positive diffuse large B-cell lymphoma (DLBCL) in the phase 3 HLX01-NHL03 study. Here, we report th...

    Authors: Yan Qin, Yongping Song, Dong Wang, Ou Bai, Jifeng Feng, Xiuhua Sun, Lihua Qiu, Jianmin Yang, Yu Yang, Zhao Wang, Jianda Hu, Huaqing Wang, Hang Su, Zhengming Jin, Wenbin Qian, Chuan Jin…
    Citation: BMC Cancer 2024 24:124
  34. Brain metastasis is a common outcome in non-small cell lung cancer, and despite aggressive treatment, its clinical outcome is still frustrating. In recent years, immunotherapy has been developing rapidly, howe...

    Authors: Jin-Sheng Liu, Yu-Xiang Cai, Yong-Ze He, Jian Xu, Su-Fang Tian and Zhi-Qiang Li
    Citation: BMC Cancer 2024 24:123
  35. Ovarian cancer is one of the most common gynecological malignancies due to the lack of early symptoms, early diagnosis and limited screening. Therefore, it is necessary to understand the molecular mechanism un...

    Authors: Gendi Song, Zhengwei Sun, Man Chu, Zihan Zhang, Jiajia Chen, Zhiwei Wang and Xueqiong Zhu
    Citation: BMC Cancer 2024 24:122
  36. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are the two most common immune checkpoints targeted in triple-negative breast cancer (BC). Refining patient selection for immunotherapy is non-tr...

    Authors: Yi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, Chia-Hung Yang, Yu-Ling Hung, Yung-An Chen, Yu-Chieh Lin, Ching-Hung Lin, Jih-Hsiang Lee, Ming-Yang Wang, Wen-Hung Kuo, Yen-Yin Lin and Yen-Shen Lu
    Citation: BMC Cancer 2024 24:121
  37. Observational studies have explored the association of psychiatric disorders and the risk of brain cancers. However, the causal effect of specific mental illness on glioma remains elusive due to the lack of so...

    Authors: Wenzhuo Yang, Yu Han, Changjia He, Sheng Zhong, Fei Ren, Zhongping Chen, Yonggao Mou and Ke Sai
    Citation: BMC Cancer 2024 24:118
  38. For brain metastases (BMs) from EGFR/ALK-positive non-small cell lung cancer (NSCLC), the best time to administer tyrosine kinase inhibitors (TKIs) and brain radiotherapy (RT) has not been identified. This analys...

    Authors: Jing Qian, Zelai He, Ying Wu, Hongwei Li, Qun Zhang and Xianming Li
    Citation: BMC Cancer 2024 24:117
  39. Pancreatic adenocarcinoma (PDAC) ranks as the fourth leading cause for cancer-related deaths worldwide. N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) are closely related with poor prognosis and i...

    Authors: Xia-Qing Li, Shi-Qi Yin, Lin Chen, Aziguli Tulamaiti, Shu-Yu Xiao, Xue-Li Zhang, Lei Shi, Xiao-Cao Miao, Yan Yang and Xin Xing
    Citation: BMC Cancer 2024 24:116
  40. Selective lateral pelvic lymph node (LPN) dissection (LPND) following neoadjuvant chemoradiotherapy (nCRT) for rectal cancer is widely recognized. This study aimed to determine the effects of nCRT before LPND ...

    Authors: Zhongshi Xie, Qichen Chen, Bo Feng, Yujuan Jiang, Xin Wang, Wei Xing and Qian Liu
    Citation: BMC Cancer 2024 24:115
  41. Authors: Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen…
    Citation: BMC Cancer 2024 24:114

    The original article was published in BMC Cancer 2024 24:16

  42. Extracellular vesicles (EVs) have been revealed to facilitate the development of oral squamous cavity cell carcinoma (OCSCC), while its supporting role in lymph node metastases is under continuous investigatio...

    Authors: Tianzhu Lv, Hongjing Liu, Ling Mao, Yanrong Song, Lili Liao, Kun Zhong, Binbin Shuai, Yingkun Luo, Tingting Guo, Wentao Huang and Shenyingjie Zhang
    Citation: BMC Cancer 2024 24:113
  43. Since the Z0011 trial, the assessment of axillary lymph node status has been redirected from the previous assessment of the occurrence of lymph node metastasis alone to the assessment of the degree of lymph no...

    Authors: Hua Shao, Yixin Sun, Ziyue Na, Hui Jing, Bo Li, Qiucheng Wang, Cui Zhang and Wen Cheng
    Citation: BMC Cancer 2024 24:112
  44. Myelodysplastic syndrome (MDS) is known to arise through the pathogenic bone marrow mesenchymal stem cells (MSC) by interacting with hematopoietic stem cells (HSC). However, due to the strong heterogeneity of ...

    Authors: Chunlai Yin, Yanqi Li, Cheng Zhang, Shizhu Zang, Zilong Wang, Xue Yan, Tonghui Ma, Xia Li and Weiping Li
    Citation: BMC Cancer 2024 24:111
  45. Lymphoplasmacyte-rich meningioma(LPM) is a rare subtype of meningioma with a low degree of malignancy and an overall preferable prognosis. The purpose of this article is to increase the understanding of the di...

    Authors: Xiaoxi Zhu, Yanhua Liu, Weiwei Guo, Qi Liang, Chengliang Pan, Bin Tan and Ying Yu
    Citation: BMC Cancer 2024 24:110
  46. There is an aberrant expression of NBAT-1 in various human cancers, which was proven to limit the proliferation, invasion, and metastasis of tumour cells via multiple approaches. Most existing research focuses...

    Authors: Yang Yu, Kedi Fan, Tingting Ni, Xun Lei Zhang, Xiaoqin Su and Lei Yang
    Citation: BMC Cancer 2024 24:109
  47. In neuro-oncology, the inclusion of tumor patients in the molecular tumor board has only become increasingly widespread in recent years, but so far there are no standards for indication, procedure, evaluation,...

    Authors: Lisa S. Hönikl, Sebastian Lange, Vicki M. Butenschoen, Claire Delbridge, Bernhard Meyer, Stephanie E. Combs, Anna Lena Illert and Friederike Schmidt-Graf
    Citation: BMC Cancer 2024 24:108

Featured videos

View featured videos from across the BMC-series journals